Last 12 months
Inside the activity.
3 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2021 Filed Mar 15, 2021 23:32 UTC |
Baltimore Thomas J JrDirector
|
GrantNotional Shares - Mandatory · Derivative | 136 | $92.41 Strike: $0.00 | $12,567.76 |
DisclosureSEC source: 0001127602-21-010656 · form4.xml · derivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,093 Underlying: Common Stock · 136 shares Expires not disclosed F1 · derivative.exercise_price: Each notional share - mandatory represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock under the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.exercise_date: Such shares are issuable, at the election of the reporting person, to begin on either (i) a date prior to the reporting person's retirement date, provided that such date is no earlier than the January 1 in the year following the plan period during which such fees would otherwise have been payable to the reporting person, (ii) within 90 days following the reporting person's retirement date, or (iii) such later date as selected by the reporting person, provided however, that payment must commence in the year the reporting person attains age 70 1/2. F2 · derivative.expiration_date: Such shares are issuable, at the election of the reporting person, to begin on either (i) a date prior to the reporting person's retirement date, provided that such date is no earlier than the January 1 in the year following the plan period during which such fees would otherwise have been payable to the reporting person, (ii) within 90 days following the reporting person's retirement date, or (iii) such later date as selected by the reporting person, provided however, that payment must commence in the year the reporting person attains age 70 1/2. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 18:44 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
SaleCommon Stock | 5,000 | $94.11 | $470,550.00 |
DisclosureSEC source: 0001127602-21-009856 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,497 F1 · balance_after: Following the transaction reported on this Form 4, Mr. Schmidt continues to hold 16,497 shares directly and 243 shares indirectly in a 401(k) account. Mr. Schmidt also holds an additional 28,600 vested stock options, 7,597 unvested stock options, 6,264 restricted stock units and 32,374 target performance shares (the exact number awarded being dependent on achievement of performance goals). Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 18:36 UTC |
Silitch Nicholas CSenior Vice President
|
SaleCommon Stock | 8,200 | $90.62 | $743,084.00 |
DisclosureSEC source: 0001127602-21-009851 · form4.xml · nonDerivative · entry 1 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,306 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.62 to $90.67 inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Following the transactions reported on this Form 4, Mr. Silitch continues to hold 11,306 shares directly and 433 shares indirectly in a 401(k) account. Mr. Silitch also holds an additional 63,083 vested stock options, 14,817 unvested stock options, 9,948 restricted stock units, and 57,206 target performance shares (the exact number awarded being dependent on achievement of performance goals). Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 19:50 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
GrantDeferred Compensation Shares · Derivative | 1,057 | $86.72 Strike: $0.00 | $91,663.04 |
DisclosureSEC source: 0001127602-21-008638 · form4.xml · derivative · entry 1 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Underlying: Common Stock · 1,057 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Compensation Shares are based on unitized accounting and convert to common stock on a 1 to 1 basis. F2 · derivative.exercise_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. F2 · derivative.expiration_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. Read SEC document |
| February 17, 2021 Filed Mar 2, 2021 19:53 UTC |
SCOVANNER DOUGLAS ADirector
|
GiftCommon Stock | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-008640 · form4.xml · nonDerivative · entry 2 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,086 F1 · shares: The transaction involved a gift of securities by the spouse to the reporting person, who shares the reporting person's household. Read SEC document |
| February 17, 2021 Filed Mar 2, 2021 19:53 UTC |
SCOVANNER DOUGLAS ADirector
|
GiftCommon Stock | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-008640 · form4.xml · nonDerivative · entry 1 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 0 F1 · shares: The transaction involved a gift of securities by the spouse to the reporting person, who shares the reporting person's household. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 16:09 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversion2018 Restricted Stock Units · Derivative | 5,251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006080 · form4.xml · derivative · entry 4 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F4 · derivative.exercise_date: The Restricted Stock Units will vest on February 13, 2021. F4 · derivative.expiration_date: The Restricted Stock Units will vest on February 13, 2021. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 16:09 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Tax withholdingCommon Stock | 1,876 | $80.86 | $151,693.36 |
DisclosureSEC source: 0001127602-21-006080 · form4.xml · nonDerivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,497 F2 · shares: Represents shares withheld for the payment of taxes when restricted shares vested. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 16:09 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 5,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006080 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of previously awarded restricted stock units. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 16:18 UTC |
Jones Wendy ElizabethDirector
|
PurchaseCommon Stock | 1,000 | $80.98 | $80,980.00 |
DisclosureSEC source: 0001127602-21-004824 · form4.xml · nonDerivative · entry 1 Jones Wendy Elizabeth · CIK 0001723472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:55 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversion2018 Performance Shares · Derivative | 9,845 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-21-005276 · form4.xml · derivative · entry 7 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,845 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:55 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2021 Performance Shares · Derivative | 82,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005276 · form4.xml · derivative · entry 6 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,894 Underlying: Common Stock · 82,894 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:55 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2021 Restricted Stock Units · Derivative | 27,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005276 · form4.xml · derivative · entry 5 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,632 Underlying: Common Stock · 27,632 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:55 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Tax withholdingCommon Stock | 8,853 | $81.43 | $720,899.79 |
DisclosureSEC source: 0001127602-21-005276 · form4.xml · nonDerivative · entry 2 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,195 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:55 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversionCommon Stock | 20,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005276 · form4.xml · nonDerivative · entry 1 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:49 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversion2018 Performance Shares · Derivative | 11,690 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005273 · form4.xml · derivative · entry 6 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:49 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2021 Performance Shares · Derivative | 104,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005273 · form4.xml · derivative · entry 5 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,078 Underlying: Common Stock · 104,078 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:49 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2021 Restricted Stock Units · Derivative | 34,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005273 · form4.xml · derivative · entry 4 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,693 Underlying: Common Stock · 34,693 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:49 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Tax withholdingCommon Stock | 11,782 | $81.43 | $959,408.26 |
DisclosureSEC source: 0001127602-21-005273 · form4.xml · nonDerivative · entry 2 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,809 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:49 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversionCommon Stock | 24,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005273 · form4.xml · nonDerivative · entry 1 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:45 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversion2018 Performance Shares · Derivative | 6,399 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005271 · form4.xml · derivative · entry 6 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,399 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:45 UTC |
Sleyster ScottExecutive Vice President
|
Grant2021 Performance Shares · Derivative | 40,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005271 · form4.xml · derivative · entry 5 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,526 Underlying: Common Stock · 40,526 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:45 UTC |
Sleyster ScottExecutive Vice President
|
Grant2021 Restricted Stock Units · Derivative | 13,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005271 · form4.xml · derivative · entry 4 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,509 Underlying: Common Stock · 13,509 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:45 UTC |
Sleyster ScottExecutive Vice President
|
Tax withholdingCommon Stock | 5,396 | $81.43 | $439,396.28 |
DisclosureSEC source: 0001127602-21-005271 · form4.xml · nonDerivative · entry 2 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,015.12 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:45 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversionCommon Stock | 14,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005271 · form4.xml · nonDerivative · entry 1 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,411.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:43 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversion2018 Performance Shares · Derivative | 2,462 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005270 · form4.xml · derivative · entry 6 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:43 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2021 Performance Shares · Derivative | 40,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005270 · form4.xml · derivative · entry 5 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,526 Underlying: Common Stock · 40,526 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:43 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2021 Restricted Stock Units · Derivative | 13,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005270 · form4.xml · derivative · entry 4 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,509 Underlying: Common Stock · 13,509 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:43 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Tax withholdingCommon Stock | 1,819 | $81.43 | $148,121.17 |
DisclosureSEC source: 0001127602-21-005270 · form4.xml · nonDerivative · entry 2 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,203 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:43 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversionCommon Stock | 5,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005270 · form4.xml · nonDerivative · entry 1 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:42 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversion2018 Performance Shares · Derivative | 1,785 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005269 · form4.xml · derivative · entry 6 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:42 UTC |
TANJI KENNETHEVP and CFO
|
Grant2021 Performance Shares · Derivative | 33,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005269 · form4.xml · derivative · entry 5 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,158 Underlying: Common Stock · 33,158 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:42 UTC |
TANJI KENNETHEVP and CFO
|
Grant2021 Restricted Stock Units · Derivative | 11,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005269 · form4.xml · derivative · entry 4 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,503 Underlying: Common Stock · 11,503 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:42 UTC |
TANJI KENNETHEVP and CFO
|
Tax withholdingCommon Stock | 1,384 | $81.43 | $112,699.12 |
DisclosureSEC source: 0001127602-21-005269 · form4.xml · nonDerivative · entry 2 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,634 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:42 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversionCommon Stock | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005269 · form4.xml · nonDerivative · entry 1 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversion2018 Performance Shares · Derivative | 4,923 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005268 · form4.xml · derivative · entry 5 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,923 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
Alziari LucienExecutive Vice President
|
Grant2021 Performance Shares · Derivative | 20,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005268 · form4.xml · derivative · entry 4 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,724 Underlying: Common Stock · 20,724 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
Alziari LucienExecutive Vice President
|
Grant2021 Restricted Stock Units · Derivative | 6,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005268 · form4.xml · derivative · entry 3 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,908 Underlying: Common Stock · 6,908 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
Alziari LucienExecutive Vice President
|
Tax withholdingCommon Stock | 3,800 | $81.43 | $309,434.00 |
DisclosureSEC source: 0001127602-21-005268 · form4.xml · nonDerivative · entry 2 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,881 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversionCommon Stock | 10,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005268 · form4.xml · nonDerivative · entry 1 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:38 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2021 Performance Shares · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005267 · form4.xml · derivative · entry 2 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed F3 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F4 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F4 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:38 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2021 Restricted Stock Units · Derivative | 5,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005267 · form4.xml · derivative · entry 1 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F2 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F2 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:37 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversion2018 Performance Shares · Derivative | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005266 · form4.xml · derivative · entry 6 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 1,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:37 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2021 Performance Shares · Derivative | 16,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005266 · form4.xml · derivative · entry 5 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,119 Underlying: Common Stock · 16,119 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:37 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2021 Restricted Stock Units · Derivative | 5,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005266 · form4.xml · derivative · entry 4 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,373 Underlying: Common Stock · 5,373 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:37 UTC |
KAPPLER ANN MEVP and General Counsel
|
Tax withholdingCommon Stock | 1,019 | $81.43 | $82,977.17 |
DisclosureSEC source: 0001127602-21-005266 · form4.xml · nonDerivative · entry 2 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,022 F3 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:37 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversionCommon Stock | 2,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005266 · form4.xml · nonDerivative · entry 1 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F2 · shares: Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:35 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversion2018 Performance Shares · Derivative | 6,399 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005264 · form4.xml · derivative · entry 6 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,399 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:35 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2021 Performance Shares · Derivative | 23,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005264 · form4.xml · derivative · entry 5 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,211 Underlying: Common Stock · 23,211 shares Expires not disclosed F7 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F8 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. F8 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:35 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2021 Restricted Stock Units · Derivative | 9,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005264 · form4.xml · derivative · entry 4 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,948 Underlying: Common Stock · 9,948 shares Expires not disclosed F5 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. F6 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.